Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines Tel. No. 238-6300 Website: http://www.ipophil.gov.ph e-mail: [email protected]Volume 21 Number 136 Date Released: December 12, 2018 Invention Granted Under R.A. 8293 (PCT) 1 INVENTIONS [19] INTELLECTUAL PROPERTY PHILIPPINES [12] INVENTION GRANT [21] Registration Number: 1/2010/502568 Document Code: B1 [45] Issue Date: 10 August 2018 [22] Date Filed: 15 November 2010 [54] Title: LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF [71] Proprietors(s): ASHA NUTRITION SCIENCES, INC. [US] [72] Inventor(s): BHAGAT, URVASHI[US] [73] Assignee(s): ASHA NUTRITION SCIENCES, INC. [US] [74] Attorney / Agent: ORTEGA DEL CASTILLO BACORRO ODUIO CALMA & CARBONELL [30] Priority Data: NONE [51] International Class 8: A23D 7/00; A23L 1/29; A61K 9/107 [57] Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area. Representative Drawing(s): NONE [56] Reference(s) Cited and/or Considered: Document description US 2005/0054724 A1 (MUSTAD, ET AL.) 10 March 2005. US 2006/0088574 A1 (MANNING, ET AL.) 27 April 2006. WO 2005/065468 A1 (SHARP INGRAINED FUNCTIONAL FOODS INC.) 21 July 2005. US 6159507 A (IGARASHI) 12 December 2000. JP 03-053869 A (NIPPON OIL & FATS CO LTD) 07 March 1991. RENAUD, S. ,ET AL. "Cretan Mediterranean Diet for Prevention of Coronary Heart Disease" AMERICAN JOURNAL OF CLINICAL NUTRITION 1995, Vol. 61, pages 1360S-1367S.
Transcript
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: A23D 7/00; A23L 1/29; A61K 9/107
[57] Abstract:
Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US 2005/0054724 A1 (MUSTAD, ET AL.) 10 March 2005.
US 2006/0088574 A1 (MANNING, ET AL.) 27 April 2006.
WO 2005/065468 A1 (SHARP INGRAINED FUNCTIONAL FOODS INC.) 21 July 2005.
US 6159507 A (IGARASHI) 12 December 2000.
JP 03-053869 A (NIPPON OIL & FATS CO LTD) 07 March 1991.
RENAUD, S. ,ET AL. "Cretan Mediterranean Diet for Prevention of Coronary Heart Disease" AMERICAN JOURNAL OF CLINICAL NUTRITION 1995, Vol. 61, pages 1360S-1367S.
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
BERGLUND, D.R., "Flax: New Uses and Demands" In: J. Janick and A. Whipkey (eds.), Trends in new crops and new uses. 2002. ASHS Press, Alexandria, VA, Pages 358-360.
No. of Claims: 69
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
A composition as the stabilizer for preparing the freeze-dried vaccine and the method for producing the freeze-dried vaccine using the composition are disclosed. The composition comprises human serum albumin, sucrose, trehalose, dextran, sodium glutamate, urea and arginine with the initial concentration in the stock solution before freeze-drying of 3-20 g/l, 30-100 g/l, 10-30 g/l, 10-50 g/l, 6-12 g/l, 3-9 g/l and 0.5-2 g/l, respectively. The composition does not contain gelatin.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
CN 1214938 A (CHANGCHUN BIOLOGICAL PROD INST MIN PUBL) 28 April 1999.
US 6,210,683 B1 (BURKE, CARL AND VOLKIN, DAVID) 03 April 2001.
US 2008/0248551 A1 (STINCHCOMB, D.T., OSORIO, J.E., ET AL.) 09 October 2008.
NAKAYAMA, T., ET AL.: "A clinical analysis of gelatin allergy and determination of its causal relationship..." Dept. of Virology, The Kitasato Ins., Tokyo and the Depart. of Pedia., School of Med., Tokai Univ., Kanagawa, 05 November 1998.
No. of Claims: 10
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: A61K 38/18; A61K 38/26; A61P 3/00
[57] Abstract:
(EN): The invention is directed to a pharmaceutical composition containing at least one FGF-21 (fibroblast growth factor 21) compound, at least one GLP-1R (glucagon-like peptide-1 receptor) agonist and optionally at least one anti-diabetic drug and/or at least one DPP-4 (dipeptidyl peptidase-4) inhibitor for the treatment of at least one metabolic syndrome and/or atherosclerosis, in particular diabetes, dyslipidemia, obesity and/or adipositas.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
JP 2002 112772 A (TAKEDA CHEMICAL INDUSTRIES LTD) 16 April 2002
WO 2003/011213 A2 (LI LLY CO ELI [US]; GLASEBROOK ANDREW LAWRENCE [US]; HAMMOND LISA JANIN) 13 February 2003
No. of Claims: 21
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW OFFICES
[30] Priority Data: 12/980,825 29/12/2010 US and 12/980,833 29/12/2010 US
[51] International Class 8: A23J 1/20; A23L 1/29; A23L 1/305; A61K 35/20; A61K 38/40
[57] Abstract:
The present disclosure relates to the use of nutritional compositions including lactoferrin from a non-human source in supporting resistance to diseases or conditions. The method includes administering to a human a nutritional composition comprising a fat or lipid source, a protein source and lactoferrin produced by a non-human source.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
WO 2006/121507 A1 16 November 2006 (16.11.2006)
WO 2009/068549 A1 04 June 2009 (04.06.2009)
SUNILKUMAR, P. et al. "Conformation of a residue substituted fragment (349-364) of human lactoferrin protein in DMSO-d6 by 1H NMR and restrained molecular dynamics". February 2008
No. of Claims: 10
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[54] Title: OLIGOSACCHARIDE COMPOSITION FOR TREATING ACUTE RESPIRATORY TRACT INFECTIONS
[71] Proprietors(s): NESTEC S.A. [CH]
[72] Inventor(s): SPRENGER, Norbert[LI]
[73] Assignee(s): NESTEC S.A. [CH]
[74] Attorney / Agent: BENGZON NEGRE & UNTALAN
[30] Priority Data: 10192230.0 23/11/2010 EP
[51] International Class 8: A23L 1/09; A61K 31/702; A61K 35/00; A61K 45/06; A61P 11/00; A61P 27/16; A61P 31/00; C12N 1/00
[57] Abstract:
The inventions discloses a composition comprising at least one N-acetyl lactosamine, at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide, for use in preventing acute respiratory infections (ARI) and/or relieving symptoms of said ARI infections. Preferably said composition is a starter infant formula. Said acute respiratory infection is in particular bronchiolitis or otitis.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
WO 2007/144334 A1 (NESTEC SA [CH]; FICHOT MARIE-CLAIRE [CH]; BRUESSOW HARALD [CH]) 21 December 2007
DEBARBI EUX et al., "Bacteriophages can treat and prevent pseudomonas aeruginosa lung infections", Journal of Infectious Diseases, vol. 201, no. 7, 1 April 2010, pages 1096-1104
No. of Claims: 25
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[54] Title: LYOPHILIZED PREPARATION OF BOTULINUM TOXIN
[71] Proprietors(s): MEDY-TOX INC. [KR]
[72] Inventor(s): JUNG, Hyun Ho[KR]: YANG, Gi Hyeok [KR]: RHEE, Chang Hoon[KR]: KIM, Hack Woo[KR]: KIM, Sung Bum[KR]: BAEK, Seung Hwan[KR]
[73] Assignee(s): MEDY-TOX INC. [KR]
[74] Attorney / Agent: HECHANOVA AND CO., INC.
[30] Priority Data: 10-2011-0029577 31/03/2011 KR and 10-2012-0033374 30/03/2012 KR
[51] International Class 8: A61K 35/74; A61K 38/17; A61P 13/10
[57] Abstract:
There are provided a lyophilized preparation of botulinum toxin without a protein stabilizer derived from animals. The lyophilized preparation of botulinum toxin according to the present invention can maintain an activity of botulinum toxin, and also exhibit excellent long-term stability even under conditions of high temperature, which may occur when botulinum toxin is stored, delivered and processed.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US 2012/0141619 A1 (ALLERGAN INC.) 07 June 2012
US 2010/279953 A1 (ALLERGAN INC.) 4 November 2010
WO 97/35604 A1 (WISCONSIN ALUMNI RESEARCH FOUNDATION) 02 October 1997
No. of Claims: 12
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: C09K 19/00; G02B 1/10; G02B 5/23
[57] Abstract:
Provided are photochromic articles that include a substrate, a primer layer that includes a first photochromic compound, and a photochromic-dichroic layer over the primer layer that includes a photochromic-dichroic compound. The first photochromic compound and the photochromic-dichroic compound each are selected such that the photochromic-dichroic compound has an absorbance of less than or equal to 0.1 at the wavelength of peak absorbance of the underlying first photochromic compound. The present invention also relates to such photochromic articles that further include a topcoat layer over the photochromic-dichroic layer. The topcoat layer can include a second photochromic compound that has an absorbance of less than 0.1 at the wavelength of peak absorbance of the underlying photochromic-dichroic compound. The photochromic articles provide, for example, a combination of linear polarizing properties, and reduced percent transmittance when in a colored or darkened state, such as when exposed to actinic light.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US 2011/129678 A1 (HE MENG [US] et. al.) 2 June 2011
US 2007/275234 A1 (LIM SUNG-HYUN [KR] et. al.) 29 November 2007
No. of Claims: 21
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: A61K 38/00; A61K 47/10; A61K 47/14; A61K 47/24; A61K 9/00; A61K 9/127
[57] Abstract:
The present invention relates to compositions forming a low viscosity mixture of: a) 20-80 wt.% of at least one diacyl glycerol and/or a tocopherol; b) 20-80 wt.% of at least one phosphatidyl choline (PC); c) 5-20 wt.% of at least one biocompatible, organic mono-alcoholic solvent; d) up to 20 wt.% polar solvent e) at least one peptide active agent; f) optionally at least one antioxidant; wherein the ratio of components a:b is in the range 40:60 to 54:46; wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with excess aqueous fluid. The invention further relates to methods of treatment comprising administration of such compositions, and to pre-filled administration devices and kits containing the formulations.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
WO 2006075124 A1 CAMURUS AB 20 July 2006 (20.07.2006)
US 20090155193 A1 JOABSSON et al. 18 June 2009 (18.06.2009)
No. of Claims: 37
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: F04F 9/00; F22B 33/16; F22B 35/06; F22D 5/26
[57] Abstract:
The present invention relates to an energy-saving pump, and to a control system for the pump, wherein the pump comprises: a pump body installed to receive steam from a steam generator; a steam transfer means for opening/closing a pipeline between the pump body and the steam generator; and a water supply means for opening/closing a pipeline between the pump body and a water usage space, wherein the steam transfer means and the water supply means are opened to supply water to the water usage space. The present invention further relates to an energy-saving pump, and to a control system for the pump, wherein the pump comprises: a pump body arranged to receive steam from a steam generator; a steam transfer means for opening/closing a pipeline between the pump body and the steam generator; and a suction means for opening/closing a pipeline between the pump body and a water source, wherein the steam transfer means is closed to receive steam and then the suction means is opened to suction water from the water source.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
KR 10-0746517 B1 (KIM, IL SANG) 06 August 2007
KR 20-1992-0000504 Y1 (PARK, KI-JUN et al.) 15 January 1992
KR 10-2011-0026596 A (YIM, JOO HYUK) 16 March 2011
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
The present invention provides compounds of Formula (I):
or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
WO 2005/014533 A2 (TRANSTECH PHARMA INC) 17 February 2005 (17.02.2005)
WO 03/041641 A2 (SQUIBB BRISTOL MYERS CO) 22 May 2003 (22.05.2003)
WO 03/041641 A2 (SQUIBB BRISTOL MYERS CO) 22 May 2003 (22.05.2003)
No. of Claims: 19
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: C07D 311/94; C09K 9/02; G02B 5/23; G03C 1/685
[57] Abstract:
The present invention relates to photochromic materials that include certain indeno-fused naphthopyrans. The indeno-fused naphthopyrans have an amino group (e.g., a piperidino or morpholino group) bonded to the 6-position and hydrogen or a halo group (e.g., fluoro) bonded to the 11-position thereof. The photochromic materials of the present invention can have a closed-form electromagnetic radiation absorption spectrum that is shifted to longer wavelengths (e.g., wavelengths of greater than 390 nm), relative to comparable photochromic materials. The present invention also relates to optical elements, such as eyeglasses, that include the photochromic materials of the present invention.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
WO 2007/073462 A1 (TRANSITIONS OPTICAL, INC.); 28 June 2007
WO 01/19813 A1 (TRANSITIONS OPTICAL, INC.); 22 March 2001
No. of Claims: 9
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[73] Assignee(s): YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. [IL]
[74] Attorney / Agent: E. B. ASTUDILLO & ASSOCIATES
[30] Priority Data: 61/559, 964 15/11/2011 US and 61/603, 508 27/02/2012 US
[51] International Class 8: A61K 31/14
[57] Abstract:
Tricyclic compounds, compositions and uses thereof in the treatment of at least one disease, disorder or condition such as for example obesity, overweight, abnormal fat- distribution and any conditions or disease associated therewith.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US2676966 (CUSIC JOHN ET AL.) 27 April 1954
"Unexpected Salt Effects on Charge Separation Yields in Phenothiazine Derivatives-Methylviologen Systems" (KAWANISHI ET AL.) 1986
No. of Claims: 20
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW OFFICES
[30] Priority Data: 2011-247031 11/11/2011 JP and 61/558,685 11/11/2011 US
[51] International Class 8: C12N 15/09; C12P 7/50
[57] Abstract:
By culturing a bacterium having an ability to produce 2-ketoglutaric acid or a derivative thereof, and an ability to produce xylonic acid from xylose, which is imparted with xylonate dehydratase activity, 2-keto-3-deoxyxylonate dehydratase activity and 2-ketoglutaric acid semialdehyde dehydrogenase activity, or in which these activities are enhanced, in a medium containing xylose as the carbon source to produce and accumulate the target substance in the medium, and collecting the target substance from the medium, the target substance is produced.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
MEIJNEN ET AL: Ëstablishment of oxidative D-xylose metabolism in Pseudomonas putida S12", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 75, 2009, pp. 2784-2791, XP002740682.
JOHNSEN ET AL: "D-xylose degradation pathway in the halophilic archaeon Haloferax volcanii", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol 284, 2009, pp. 27290-27303, XP002740683.
KATASHKINA ET AL: "Use of the lambda red-recombineering metod for genetic enrineering of Pantoea ananatis", BMC MOLECULAR BIOLOGY, vol. 10, 2009, pp. 1-11. XP021048298.
No. of Claims: 22
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: A45D 34/00; A45D 37/00; A45D 40/00; A61K 8/67
[57] Abstract:
The present invention relates to a cosmetic composition carrier in which one or more foams having a number of pores in the range of 10ppi to 130ppi are impregnated with a cosmetic composition having a viscosity of 1,000 to 5,000cps and 15,000 to 100,000 cps so as to enable a user to carry a compact type liquid cosmetic composition.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
JP 2003-012457 A (POLA CHEMICAL INDUSTRIES, INC)
JP 2002-125755 A (L'OREAL SA)
US 6883995 B1 (GUERET, JEAN-LOUIS H)
No. of Claims: 28
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
Disclosed is a cosmetic composition carrier having a viscosity of 1,500 to 4,000 centipoise (cps) or 20,000 to 55,000 cps. The cosmetic composition carrier comprises a urethane foam having a hardness before impregnation of 1 to 100 on the Asker durometer type F.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
JP 2003-012457 A (POLA CHEMICAL INDUSTRIES INC) 15 January 2003
KR 10-2009-0100643 A (AMOREPACIFIC CORPORATION) 24 September 2009
JP 2008-264060 A (INOAC CORP) 06 November 2008
No. of Claims: 4
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
Provided herein are compounds according to Formulas (I) or (II) and pharmaceutically acceptable salts thereof, and compositions comprising the same, for use in various methods, including treating cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, osteoarthritis, idiopathic pulmonary fibrosis and neurological conditions/disorders/diseases. Formula (I) and (II).
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US 2011/190290 A1 (Hood, J. et. al.); 04 August 2011
No. of Claims: 210
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: C12N 1/16; C12P 7/08; C12P 7/40; C12R 1/645
[57] Abstract:
The present invention relates to a method for producing bioproducts, comprising the steps of: culturing a first microorganism to produce bioalcohol; hydrolyzing the first microorganism; separating the bioalcohol; acquiring waste from the hydrolyzed bioalcohol fermentation; and inoculating the wastes from the hydrolyzed bioalcohol fermentation with a second microorganism.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
D1 US8685684 B2 (LEE et al.) 01 April 2014
D2 US20020164731 (EROMA et al.) 3 October 2017
No. of Claims: 13
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[73] Assignee(s): SUNESIS PHARMACEUTICALS, INC [US] and BIOGEN MA INC. [US]
[74] Attorney / Agent: CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW OFFICES
[30] Priority Data: 61/657,360 08/06/2012 US
[51] International Class 8: A01N 43/40; A61K 31/435; A61K 31/445
[57] Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
WO 2011/029046 A1 (BIOGEN IDEC MA INC. [US]) 10 March 2011
No. of Claims: 186
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[54] Title: N-ACYLHYDRAZONE DERIVATIVES FOR SELECTIVE T CELL INHIBITOR AND ANTI-LYMPHOID MALIGNANCY DRUG
[71] Proprietors(s): CHONG KUN DANG PHARMACEUTICAL CORP. [KR] and INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR]
[72] Inventor(s): CHOI, HoJin[KR]: LEE, JaeWon[KR]: LEE, ChangGon[KR]: HA, NiNa[KR]: SEO, Su Kil[KR]: LEE, SunMi[KR]: LEE, Song-Min[KR]
[73] Assignee(s): CHONG KUN DANG PHARMACEUTICAL CORP. [KR] and INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR]
[74] Attorney / Agent: A.Q. ANCHETA AND PARTNERS
[30] Priority Data: 10-2012-0095729 30/08/2012 KR and 10-2012-0108972 28/09/2012 KR
[51] International Class 8: A61K 31/404; A61P 29/00; A61P 35/00; C07D 209/04
[57] Abstract:
The present invention relates to novel N-acylhydrazone derivatives, and more particularly to novel N-acylhydrazone derivatives having selective T cell inhibitory activity and/or anti-lymphoid malignancy activity, stereoisomers thereof, pharmaceutically acceptable salts thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing the same, treatment methods using the compositions, and methods for preparing the novel N-acylhydrazone derivatives.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
WO 2008/121877 (RUSSELL, et al.) 09 October 2008 (09.10.2008)
WO 2009/155362 (PICKENS, et al.) 23 December 2009 (23.12.2009)
WO 2006/121684 (CARDOZO, et al.) 16 November 2006 (16.11.2006)
No. of Claims: 72
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[54] Title: PLASMA SOURCE AND METHODS FOR DEPOSITING THIN FILM COATINGS USING PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION
[71] Proprietors(s): AGC GLASS EUROPE [BE]; AGC FLAT GLASS NORTH AMERICA, INC. [US] and ASAHI GLASS CO., LTD [JP]
[72] Inventor(s): MASCHWITZ, Peter[US]
[73] Assignee(s): AGC GLASS EUROPE [BE]; AGC FLAT GLASS NORTH AMERICA, INC. [US] and ASAHI GLASS CO., LTD [JP]
[74] Attorney / Agent: SYCIP, SALAZAR, HERNANDEZ AND GATMAITAN
[30] Priority Data: 61/137,839 04/08/2008 US
[51] International Class 8: H01L 21/469; H05H 1/00
[57] Abstract:
The present invention provides novel plasma sources useful in the thin film coating arts and methods of using the same. More specifically, the present invention provides novel linear and two dimensional plasma sources that produce linear and two dimensional plasmas, respectively, that are useful for plasma-enhanced chemical vapor deposition. The present invention also provides methods of making thin film coatings and methods of increasing the coating efficiencies of such methods.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US6444945 (B1) (MASCHWITZ ET AL 09/2002)
No. of Claims: 6
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[54] Title: BUFFERING PERIOD AND RECOVERY POINT SUPPLEMENTAL ENHANCEMENT INFORMATION MESSAGES
[71] Proprietors(s): QUALCOMM INCORPORATED [US]
[72] Inventor(s): WANG, Ye-Kui[US]
[73] Assignee(s): QUALCOMM INCORPORATED [US]
[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES
[30] Priority Data: 14/033,329 20/09/2013 US; 61/705,119 24/09/2012 US and 61/708,475 01/10/2012 US
[51] International Class 8: H04N 7/26
[57] Abstract:
A video coding device, such as a video decoder, may be configured to decode a buffering period supplemental enhancement information (SEI) message associated with an access unit (AU). The video decoder is further configured to decode a duration between coded picture buffer (CPB) removal time of a first decoding unit (DU) in the AU and CPB removal time of a second DU from the buffering period SEI message, wherein the AU has a TemporalId equal to 0. The video decoder is configured to determine a removal time of the first DU based at least in part on the decoded duration and decode video data of the first DU based at least in part on the removal time.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US2011/0216836 A1 (LUO et. al.) 08 September 2011
US2011/0026593 A1 (NEW et. al.) 03 February 2011
No. of Claims: 8
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: SALUDO FERNANDEZ AND AQUINO (SAFA LAW)
[30] Priority Data: 12306232.5 09/10/2012 EP and 13305222.5 27/02/2013 EP
[51] International Class 8: A61K 38/26; C07K 14/575; C07K 14/605
[57] Abstract: The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
WO2008081418 A1 COVX TECHNOLOGIES IRELAND LTD 10 July 2008 (10.07.2008)
WO2011117415 A1 NOVO NORDISK A/S 29 September 2011 (29.09.2011)
WO2004035623 A2 ZEALAND PHARMA A/S 29 April 2004 (29.04.2004)
No. of Claims: 32
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[71] Proprietors(s): VIFOR (INTERNATIONAL) AG [CH]
[72] Inventor(s): WEIBEL-FURER, Ludwig [CH]: PHILIPP, Erik[CH]
[73] Assignee(s): VIFOR (INTERNATIONAL) AG [CH]
[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES
[30] Priority Data: 07120837.5 16/11/2007 EP
[51] International Class 8: A61K 33/26; A61K 47/02; A61K 9/14; A61K 9/70; A61P 13/12; A61P 7/08
[57] Abstract:
Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US6521247 B1 (deVries) 18 February 2003
No. of Claims: 53
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 61/711,204 08/10/2012 US; 61/719,281 26/10/2012 US; 61/840,432 27/06/2013 US and 61/872,366 30/08/2013 US
[51] International Class 8: A61K 39/395; C07K 16/18; G01N 33/53
[57] Abstract:
The invention provides monoclonal antibody 5C1 and related antibodies. The 5C1 antibody binds to an epitope within residues 118-126 of a-synuclein. The antibodies of the invention are useful, for example, for treating and/or diagnosing disorders associated with a-synuclein, particularly accumulation of a-synuclein deposits. Such disorders include Lewy body diseases, such as Parkinson's disease, Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy (MSA).
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 6719971 B1 (CARTER, Paul J. [US] and PRESTA, Leonard G.[US]) 13 APRIL 2004 (13.04.2004)
US 6881557 B2 (FOOTE, Jefferson [US]) 19 APRIL 2005 (19.04.2005)
WO 2004/039234 A2 (ALEXION PHARMA INC.) 13 MAY 2004 (13.05.2004)
No. of Claims: 26
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 61/722,511 05/11/2012 US and 61/770,535 28/02/2013 US
[51] International Class 8: A61K 38/22; A61K 47/02; A61K 47/04; A61K 47/10; A61K 47/12; A61P 15/08; A61P 5/06; C07K 9/00
[57] Abstract:
Use of a subcutaneously administered dose of between about 1.0 mg and 1.75 mg of bremelanotide or a pharmaceutically acceptable salt of bremelanotide for the treatment of female sexual dysfunction in women while reducing or minimizing undesirable side effects.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
Palatin Technologies, Inc.: "Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder" (CLINICALTRIALS.GOV; NCT01382719); 20 March 2012
M.R. Safarinejad: "Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder" (THE JOURNAL OF SEXUAL MEDICINE); April 2008
US 6794489 B2 (Blood, C.H. et. al.); 21 September 2004
US 6579968 B1 (Blood, C.H. et. al.); 17 June 2003
No. of Claims: 22
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: ORBOS CABUSORA & TAGUIAM LAW OFFICE
[30] Priority Data: 61/720,939 31/10/2012 US and 61/777,875 12/03/2013 US
[51] International Class 8: C12N 15/113
[57] Abstract:
In certain embodiments, methods, compounds, and compositions for treating B-cell lymphoma or hepatocellular carcinoma by inhibiting expression of STAT3 mRNA or protein in an animal are provided herein. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate B-celllymphoma or hepatocellular carcinoma. The STAT (signal transducers and activators of transcription) family of proteins are DNA-binding proteins that play a dual role in signal transduction and activation of transcription.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
US6784290 B1 MONIA ET AL. 8/2004
US7611839 B2 TWINE ET AL 11/2009
No. of Claims: 38
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: MANUEL C. CASES, JR. AND ASSOCIATES
[30] Priority Data: 61/362,844 09/07/2010 US
[51] International Class 8: H04N 7/26; H04N 7/50
[57] Abstract:
A method and apparatus for entropy coding and decoding a transformation block. The method of entropy coding a transformation block includes determining a location of a last significant transformation coefficient having a non-zero value from among transformation coefficients included in a transformation block having a certain size, according to a certain scan order; and coding information about the location of the last significant transformation coefficient by using its horizontal axis direction location and its vertical axis direction location in the transformation block.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 2009/0232204 A1 (LEE et al.) 17 September 2009
US2010/0034268 A1 (KUSAKABE et. al.) 11 February 2010
No. of Claims: 5
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: A61J 1/14; A61J 1/20; A61J 9/00; B65D 51/22
[57] Abstract:
A cap for use in enteral feeding from a container. The cap includes a base and an insert cutter. The base has a top surface, a bottom surface, and an outer ring. The top surface has a protruding port suitable for insertion of a spike connector. The protruding port defines a spike insertion chamber extending from a spike connector insert aperture to a spike connector outlet aperture. The outer ring is configured for attachment to a container having a mouth. The insert cutter has a first end portion attached to the bottom surface of the base and about an edge of the spike connector outlet aperture and a second end portion extending over at least a portion of the spike connector outlet aperture. The insert cutter is capable of flexing in an insertion direction of a spike connector inserted through the spike insertion chamber.
Representative Drawing(s):
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
An air stream controller and a system for static charge reduction comprising such air stream controller are disclosed. The air stream controller comprises an enclosed hollow body having a first surface and a second surface, wherein, an opening is on the first surface facing an incoming tubing of a device for static charge reduction for receiving air stream from the device for static charge reduction, wherein an outgoing tubing of the device for static charge reduction is attached onto the second surface of the enclosed hollow body for discharging the air stream. A technical solution to more effectively prevent the "leaking of air stream passage" can be achieved through the design of a multi-holes structure at the air passage to more broadly expand its air sucking area coverage without increasing the original suction power.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US7381245 B2 (Fleischer) 12 December 2003
No. of Claims: 18
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
Objects of the present invention are to provide a compound which is highly active against pests, to provide a pest control agent comprising the compound, and to provide a method for controlling a pest by applying the compound. The present invention provides a 4-(arylethynyl)pyridine or a salt thereof, a pest control agent which comprises the 4-(arylethynyl)pyridine or salt thereof as an active ingredient, and a method for controlling a pest by applying the 4-(arylethynyl)pyridine or salt thereof in an effective amount.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 6340759 B1 (UENO, K. et al.)
WO 2010115901 A1 (ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.)
No. of Claims: 6
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: MIRANDAH ASIA (PHILIPPINES) INC
[30] Priority Data: 12/585,232 09/09/2009 US
[51] International Class 8: A01N 25/30; A01N 49/00; A01N 65/00; A01P 3/00; A01P 5/00
[57] Abstract:
The invention relates to composition and methods for increasing microbial activity in soil. In particular, it relates to a method for increasing wetted soil volume available for water uptake by plant roots comprising: selecting soil in need of treatment; applying an effective amount of a composition comprising one or more surfactants and one or more high terpene based oils to the soil in need of treatment; to thereby increase wetted soil volume available for water uptake by plant roots in the soil selected for treatment compared to untreated soil.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 2008/0146444 A1, (FABRI, et al.), 19 June 2008 (19.06.2008)
WO 2006/052228 A1, (PULLEN), 18 May 2006 (18.05.2006)
No. of Claims: 15
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: Atty. E. B. ASTUDILLO & ASSOCIATES
[30] Priority Data: US 13/827,594 14/03/2013 US and US 61/752,906 15/01/2013 US
[51] International Class 8: G02B 6/44; H01J 5/00; H02B 1/50; H02G 3/08; H02G 3/18; H02J 15/00; H05K 5/00
[57] Abstract:
A grade level enclosure conversion assembly adapted for converting a pedestal housing between a flush-to-grade and an above-ground pedestal installation. The base of the pedestal housing carries a plug removably mounted to a swing-arm in the grade level enclosure. The swing-arm holds the pedestal assembly in a stored position in the flush-to-grade installation, containing wiring for service connections. To convert to the above-ground installation, a solid grade level cover plate lid is removed, and the pedestal assembly is rotated on the swing arm to a raised position from which it can be removed from the swing- arm (along with the wiring) and fed through an access opening in a separate cover plate lid. The plug on the pedestal housing is then positioned in the access opening to hold the pedestal assembly in the above-ground position. A series of separate fiber optic splice connections, or other underground utility service connections, can be made when rotating the pedestal between the stored position and the above-ground position.
Representative Drawing(s):
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 2013-025426 13/02/2013 JP and 2013-025427 13/02/2013 JP
[51] International Class 8: B25J 13/00; B25J 19/06
[57] Abstract:
The present application provides an industrial robot that makes it possible to prevent damage in an automatic operation after completion of a teaching operation. In a robot 1; wherein a torque of the motors 15, 17, 19 and 22 (hereinafter, called the motors 15 and the like) for turning the motors 15 and the like in one direction is dealt with as a plus torque, and a torque of the motors 15 and the like for turning the motors 15 and the like in the other direction is dealt with as a minus torque; a control unit 5 turns the motors 15 and the like, in a test operation for the robot 1 to be carried out after the completion of the teaching operation, at a revolution speed lower than a revolution speed in a regular operation for the robot 1 to be carried out after the completion of the test operation; and furthermore, when the motors 15 and the like turn in the one direction in the teat operation, the motors 15 and the like are controlled with reference to a torque limit value lower than a torque limit value in the case of the motors 15 and the like turn in the other direction in the test operation, the motors 15 and the like are controlled with reference to a torque limit value higher than a torque limit value in the case of the motors 15 and the like turning in the other direction in the regular operation.
Representative Drawing(s):
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[71] Proprietors(s): BCS BUSINESS CONSULTING SERVICES PTE LTD. [SG]
[72] Inventor(s): VAN WITENBURG, Jimmy[NL]: LA CROIS, Rene[NL]
[73] Assignee(s): BCS BUSINESS CONSULTING SERVICES PTE LTD. [SG]
[74] Attorney / Agent: FEDERIS & ASSOCIATES LAW OFFICES
[30] Priority Data: NONE
[51] International Class 8: C07C 41/46; C07C 43/162; C07C 45/86; C07C 49/633
[57] Abstract:
Described is a method of synthesizing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0] octan-3-one by reacting 3-(5-ethoxyhept-1-yl) cyclopentene with dichloroketene. The resulting reaction products are reacted with acetic acid and zinc to produce 4-(5-ethoxyhept-1 -yl)bicyclo[3.2.0]heptan-6-one and 4-(5-ethoxyhept-1-yl)bicyclo [3.2.0]heptan-7-one, which are reacted with trimethylsulfonium iodide to produce 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane]. Lithium iodide is reacted with 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane] to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one. A method of synthesizing 6-(5-methoxyhept-1-yl)bicyclo[3.3.0]octan-3-one is also described.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
AU2011100223 (A4) BCS BUSINESS CONSULTING SERVICES PTE LTD
No. of Claims: 9
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[72] Inventor(s): HONG, Yong Deog[KR]: KIM, Su Na[KR]: SEO, Jung A[KR]: KIM, Se Hyun[KR]: CHUNG, Hyun Jung[KR]: KANG, Byung Ha[KR]: BAE, Woo Ri[KR]: SHIN, Song Seok[KR]: PARK, Young Ho[KR]
[30] Priority Data: 10-2013-0081694 11/07/2013 KR and 10-2014-0086251 09/07/2014 KR
[51] International Class 8: A23L 33/105; A61K 31/704; A61K 36/258; A61K 8/97; A61P 17/14; A61Q 19/00; A61Q 5/02; A61Q 7/00
[57] Abstract:
A composition for promoting hair sprouting and hair growth according to the present invention contains a higher content of ginsenoside Rb2, Rc, and Rg1, and thus can provide better hair sprouting and hair growth effects compared to hair growth agents manufactured by existing techniques. Also, the composition is made very safe by using plant-based natural products and thus can be used as a skin preparation for external application for promoting hair sprouting and hair growth, and can be widely used in cosmetic compositions, pharmaceutical compositions, and food compositions, among others.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
KR 10-2011-0010593 A (KNU-INDUSTRY COOPERATION FOUNDATION) 01 February 2011
KR 10-0950426 B1 (YOUN, GUN SANG) 29 March 2010
KR 10-2012-0005195 A (SEMYUNG UNIV. DIVSION OF INDUSTRY-ACADEMY COOPERATION GROUP) 16 January 2012
No. of Claims: 34
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 1351026-8 04/09/2013 SE; 1351169-6 03/10/2013 SE and 1450152-2 12/02/2014 SE
[51] International Class 8: A61K 31/7068; A61K 31/7072; A61P 31/14; A61P 43/00; C07H 19/06; C07H 19/10; C07H 19/16
[57] Abstract:
The invention provides compounds of the formula:(I)
wherein B is a nucleobase selected from the groups (a) to (d)
and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
WO 2012/040126 A1 (ALIOS BIOPHARMA INC.) 29 March 2012
WO 02/32920 A2 (PHARMASSET LTD.) 25 April 2002
CN 101591371 A (JINKANG PHARMACEUTCAL TECH.) 02 December 2009
No. of Claims: 25
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DE LOS ANGELES
[30] Priority Data: 2013-192081 17/09/2013 JP
[51] International Class 8: E02D 3/02; E02D 3/10
[57] Abstract:
Provided is a soil-volume reduction method capable of significantly reducing the volume of soil in comparison to conventional methods. A soil-volume reduction method includes: rotating agitating blades 3 of a soil improving apparatus 1 to thereby agitate target soil 5 to a prescribed depth in a prescribed range and form a disturbed region 6 in the target soil 5; and then installing drains 7 in the target soil 5 and discharging water W in the target soil 5 out of the target soil 5 through the drains 7 to thereby increase the amount of consolidation of the target soil 5 and thus reduce the volume thereof.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
JP 2009/013679 A1 TOA CORPORATION 22 January 2009 (22.01.2009)
No. of Claims: 12
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: FEDERIS AND ASSOCIATES LAW OFFICES
[30] Priority Data: 2013-207382 02/10/2013 JP
[51] International Class 8: A61K 47/02; A61K 47/04; A61K 47/08; A61K 47/12; A61K 47/22; A61K 47/26; A61M 1/14; A61P 7/08
[57] Abstract:
The purpose of the present invention is to provide a three-pack type dialysis agent with which it is possible to set the total acetic acid ion content in a dialysis fluid at a low value and which is excellent in terms of the storage stability of glucose, etc. and can be reduced in the odor of acetic acid. Therewith, it is possible to prepare a dialysis fluid so that the bicarbonate ion concentration can be changed at will according to need, while the concentrations of trace metal ions such as potassium ions, calcium ions, and magnesium ions are kept constant. The three-pack type dialysis agent comprises agent S comprising sodium chloride, agent B comprising sodium bicarbonate, and agent A containing glucose and an electrolyte ingredient which is neither sodium chloride nor sodium bicarbonate. By making the agent A contain acetic acid and an acetic acid salt and satisfy that the molar ratio of acetic acid/acetic acid salt is 1/(0.5-2), a bicarbonate dialysis fluid having a total acetic acid ion concentration of 2 mEq/L or higher but less than 6 mEq/L can be prepared. This agent A not only is excellent in terms of the stability of the ingredients including glucose but also can be reduced in the odor of acetic acid. According to the three-pack type dialysis agent, by controlling the amounts of the agents S, B, and A to be added when preparing a dialysis fluid, the bicarbonate ion concentration and/or sodium concentration in the dialysis fluid can be also changed.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
CN 1448145 A (GUANGZHOU KANG HUAI BIOLOGY SCIENCE AND TECHNOLOGY CO., LTD.) 15 October 2003
JP 3586767 B2 (TOMITA PHARMACEUTICAL CO., LTD.) 20 August 2004
JP 2013-150767 A (TOMITA PHARMACEUTICAL CO., LTD.) 08 August 2013
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: FEDERIS AND ASSOCIATES LAW OFFICES
[30] Priority Data: 2013-207381 02/10/2013 JP
[51] International Class 8: A61K 47/02; A61K 47/04; A61K 47/08; A61K 47/12; A61K 47/26; A61K 9/08; A61M 1/14; A61P 7/08
[57] Abstract:
[Problem] To provide a solid dialysis A agent which is to be used in preparing a bicarbonate dialysis fluid, which enables the setting of a low total acetate ion content in a dialysis fluid, and which exhibits excellent storage stability of glucose or the like and a reduced acetic acid odor. [Solution] A solid dialysis A agent which is to be used in preparing a bicarbonate dialysis fluid, wherein: the solid dialysis A agent contains glucose, acetic acid and an acetate salt; at least a part of a mixture of the acetic acid with the acetate salt is an alkali metal diacetate; and the acetic acid/acetate salt molar ratio is adjusted to 1/0.5 to 1/2. This solid dialysis A agent makes it possible to prepare a bicarbonate dialysis fluid which has a total acetate ion concentration of 2 to less than 6 mEq/L. Further, the dialysis A agent exhibits excellent stability of ingredients and a reduced acetic acid odor.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
CN 1448145 A (GUANGZHOU KANG HUAI BIOLOGY SCIENCE & TECHNOLOGY CO., TLD) 15 October 2003
JP 7-59846 A (NIKKISO CO., LTD) 07 March 1995
JP 2013-150767 A (TOMITA PHARMACEUTICAL CO., LTD.) 08 August 2013
WO 9/09953 A1 (SHIMIZU PHARMACEUTICAL CO., LTD.) 04 March 1999
No. of Claims: 31
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 10-2013-0128152 25/10/2013 KR and 10-2014-0005285 15/01/2014 KR
[51] International Class 8: G02B 7/04; G03B 5/06
[57] Abstract:
Disclosed herein is a camera lens module. The camera lens module in accordance with an embodiment of the present invention includes a vibration correction carrier, a rolling unit disposed in parallel to a direction vertical to an optical axis and configured to support the vibration correction carrier, a lens barrel carrier disposed on a side opposite the vibration correction carrier based on the rolling unit, and a base configured to mount the vibration correction carrier and the lens barrel carrier on the base.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 2013/0162851 A1 SHIIKAMA, KAZUO ET AL. 27 June 2013 (27.06.2013)
US 5 943 169 B1 OKADA, TADANORI 24 August 1999
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[30] Priority Data: 201410182148.1 30/04/2014 CN and 201410682375.0 24/11/2014 CN
[51] International Class 8: G06F 9/50
[57] Abstract:
Embodiments of the present invention provide a computer, a control device, and a data processing method. The computer includes a processing unit and a control device, where the processing unit is configured to attach a tag to an application request, and send, to the control device, the attached application request; and the control device is configured to receive the attached application request, and determine, according to the tag and a prestored resource allocation policy, a quantity of resources allocated for the application request, where the resource allocation policy includes a correspondence between the tag and the quantity of resources allocated for the application request; and further configured to instruct a component of the computer to process the application request according to the quantity of resources allocated for the application request, so as to improve service quality of an application program.
Representative Drawing(s):
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[74] Attorney / Agent: E.B. ASTUDILLO AND ASSOCIATES
[30] Priority Data: 2011-078323 31/03/2011 JP and 2011-078324 31/03/2011 JP
[51] International Class 8: B21B 1/22; B21B 3/02; C21D 9/46; C22C 38/00; C22C 38/58
[57] Abstract:
Provided is a stainless steel plate having excellent washability and anti-glare property. The stainless steel plate is manufactured by performing temper rolling using a dull roller after the finish cold rolling and bright annealing. The stainless steel plate has an arithmetic mean roughness Ra of 0.2 to 1.2 µm in a direction perpendicular to a rolling direction of the steel plate surface. Furthermore, the stainless steel plate has a transfer ratio of 15 to 70% which is an area ratio of a portion onto which a dull pattern is transferred relative to the steel plate surface. In addition, the micro-pits being formed in the steel plate surface, having a depth of 0.5 µm or more, and having an opening area of 10 µm2 or more, have an existing density in the steel plate surface of 10.0 or less per 0.01 mm
2, and an opening area ratio in the steel plate surface of
1.0% or less.
Representative Drawing(s): NONE
[56] Reference(s) Cited and/or Considered:
Document description
JP 2005-212975 A1 JFE STEEL CORPORATION 11 August 2005 (11.08.2005)
JPH 08-103801 A1 NIPPON STEEL CORPORATION 23 April 1996 (23.04.1996)
No. of Claims: 10
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
[51] International Class 8: H04W 72/04; H04W 74/08
[57] Abstract:
Various communication systems may benefit from parallel preamble transmissions. In particular, communication systems of the long term evolution of the third generation partnership project may benefit from methods and systems for parallel preamble transmission in power limited situations. A method can include determining at a physical layer of a device that a predetermined condition has been met with respect to a power limited situation. The method can also include communicating an indication that the predetermined condition has been met to a higher layer of the device based on the determining that the predetermined condition has been met.
Representative Drawing(s):
[56] Reference(s) Cited and/or Considered:
Document description
US 2006/0281463 A1 (YANG) 14 December 2006 (14.12.2006)
US 2012/0250631 A1 (HAKOLA et al) 04 October 2012 (04.010.2012)
Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines
